Clinical Trial Update: Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing daily rifapentine plus isoniazid for 1 month (1HP) versus weekly high-dose rifapentine plus isoniazid for 3 months (3HP)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)
• rifapentine (rifapentine)

Snippet

Sponsor: The Aurum Institute NPC | Conditions: HIV Seropositivity, Tuberculosis | Phase 4 | Status: ACTIVE_NOT_RECRUITING